VELINOTAMIG
UNII VT894H6T3S

Substance Identification & Data

This profile provides standardized clinical and technical data for Velinotamig, uniquely identified by the FDA Unique Ingredient Identifier (UNII) VT894H6T3S.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2848586-49-0 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

VT894H6T3S

CAS Registry Number

2848586-49-0

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

VELINOTAMIG

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C211815

National Cancer Institute reference terminology for clinical and research data.

INN ID

13145

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Velinotamig. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

VELINOTAMIG

Common Names & Synonyms

IMMUNOGLOBULIN G1 (141-GLUTAMIC ACID,207-ASPARTIC ACID,218-THREONINE,235-PHENYLALANINE,236-GLUTAMIC ACID,269-GLUTAMINE,275-GLUTAMINE,332-SERINE,350-CYSTEINE,356-GLUTAMINE,367-SERINE,369-ALANINE,408-VALINE,420-GLUTAMIC ACID), BISPECIFIC, ANTI-(HUMAN TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY PROTEIN TNFRSF17) (HUMAN-MUS MUSCULUS MONOCLONAL GR1803 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL GR1803 .KAPPA.-CHAIN, (227->224'),(230->227'),(350->352')-TRIS(DISULFIDE) WITH IMMUNOGLOBULIN G1 (232'-PHENYLALANINE,233'-GLUTAMIC ACID,329'-SERINE, 352'-CYSTEINE,364'-TRYPTOPHAN) ANTI-(HUMAN CD3 ANTIGEN) (HUMAN MONOCLONAL GR1803 .GAMMA.1-CHAIN) DISULFIDE WITH HUMAN MONOCLONAL GR1803 .KAPPA.-CHAIN

IMMUNOGLOBULIN H-GAMMA1_L-KAPPA/H-GAMMA1_L-KAPPA, ANTI-(HOMO SAPIENS CD3E (CD3 EPSILON, LEU-4)) AND ANTI-(HOMO SAPIENS TNFRSF17 (TUMOR NECROSIS FACTOR (TNF) RECEPTOR SUPERFAMILY MEMBER 17, B CELL MATURATION ANTIGEN, BCMA, TNFRSF13A, CD269)), HOMO SAPIENS MONOCLONAL ANTIBODY, BISPECIFIC

VELINOTAMIG [INN]

VELINOTAMIG [WHO-DD]

External Clinical & Regulatory Resources

Previous UNIIVT87V86D7W

Next UNIIVT8NKF57PJ